登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>PCSK9 >CEA-C202

ClinMax™ Human PCSK9 ELISA Kit

For research use only.

产品概述(Product Details)

ClinMax™ Human PCSK9 ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human PCSK9 that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ClinMax™ ELISA Kit provides several benefits:

  1. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M16 guideline.
  2. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
  3. Simplified and straightforward protocols and ready-to-use reagents to save assay time.

应用说明(Application)

The kit is developed for quantitative detection of natural and recombinant human PCSK9 in serum, plasma and cell culture supernatants.

It is for research use only.

流程图(Workflow)

PCSK9 Workflow

关键信息(Key Features)

AnalytePCSK9
Assay TypeSandwich-ELISA
ReactivityHuman
Sensitivity0.45 ng/ml
Range0.625 ng/mL-20 ng/mL
Assay Time2.75 hr
Sample TypeCell Culture Supernatants, Plasma, Serum.
Sample volume50 uL
Format96-wells plate breakable into 12 x 8 wells strips

Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

存储(Storage)

Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

 

典型数据-Typical Data Please refer to DS document for the assay protocol.

PCSK9 TYPICAL DATA

For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of PCSK9 is less than 0.45 ng/mL.

 

验证(Validation)

批内差异(Intra-Assay Statistics)

Ten replicates of each of 3 samples containing different PCSK9 concentrations were tested in one assay. Acceptable criteria: CV<10%.

PCSK9 INTRA-ASSAY STATISTICS

批间差异(Inter-Assay Statistics)

3 samples containing different concentrations of PCSK9 were tested in independent assays. Acceptable criteria: CV<15%.

PCSK9 INTER-ASSAY STATISTICS

回收率(Recovery)

Recombinant PCSK9 was spiked into 3 human serum samples, and then analyzed. The average recovery of PCSK9 for serum samples is 96.4%.

PCSK9 RECOVERY

 

组分(Materials Provided)

IDComponentsSize
CEA202-C01Pre-coated Anti-PCSK9 Antibody Microplate1 plate
CEA202-C02Human PCSK9 Standard20 μg×2
CEA202-C03Biotin-Anti-PCSK9 Antibody Con. Solution100 μL
CEA202-C04Biotin-Antibody Dilution Buffer8 mL
CEA202-C05Streptavidin-HRP Con. Solution500 μL
CEA202-C06Streptavidin-HRP Dilution Buffer15 mL
CEA202-C0720× Washing Buffer50 mL
CEA202-C08Sample Dilution Buffer15 mL×2
CEA202-C09Substrate Solution12 mL
CEA202-C10Stop Solution6 mL

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
PCSK9靶点信息
英文全称:Proprotein convertase subtilisin kexin type 9
中文全称:前蛋白转化酶枯草杆菌蛋白酶Kexin-9
种类:Homo sapiens
上市药物数量:4详情
临床药物数量:27详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定